Press Releases
June 9, 2022
Gossamer Bio Announces Publication of Key Preclinical Data in the European Respiratory Journal Highlighting Seralutinib’s Potential for the Treatment of PAH
Additional Formats
May 10, 2022
Gossamer Bio Announces First Quarter 2022 Financial Results and Provides Business Update
Additional Formats
April 25, 2022
Gossamer Bio Announces GB004 Topline Results from Phase 2 SHIFT-UC Study in Ulcerative Colitis and Provides Corporate Update
Additional Formats
March 3, 2022
Gossamer Bio Announces Fourth Quarter and Full-Year 2021 Financial Results and Provides Business Update
Additional Formats
February 28, 2022
Gossamer Bio to Announce Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call and Webcast on March 3, 2022
Additional Formats